L3VLUP
ProSign in

MYGN · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

MYGNJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • MYGN
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterMYGNJNJ
Q3 20206 holders, $99m30 holders, $26.2bn
Q4 20207 holders, $170m32 holders, $26.6bn
Q1 20215 holders, $195m31 holders, $25.3bn
Q2 20214 holders, $190m37 holders, $25.6bn
Q3 20213 holders, $191m40 holders, $24.1bn
Q4 20212 holders, $106m33 holders, $25.2bn
Q1 20222 holders, $102m35 holders, $28.2bn
Q2 20223 holders, $72m33 holders, $26.9bn
Q3 20223 holders, $193m36 holders, $25.4bn
Q4 20222 holders, $77m35 holders, $27.6bn
Q1 20235 holders, $388m42 holders, $24.5bn
Q2 20236 holders, $368m38 holders, $25.0bn
Q3 20232 holders, $101m37 holders, $18.9bn
Q4 20233 holders, $286m31 holders, $19.0bn
Q1 20243 holders, $332m32 holders, $19.7bn
Q2 20247 holders, $490m35 holders, $20.4bn
Q3 20245 holders, $456m28 holders, $22.3bn
Q4 20242 holders, $95m37 holders, $20.4bn
Q1 20253 holders, $56m32 holders, $20.5bn
Q2 20251 holders, $24m31 holders, $18.4bn
Q3 20251 holders, $33m32 holders, $23.7bn
Q4 20251 holders, $28m29 holders, $27.8bn
Q1 20262 holders, $25m34 holders, $35.6bn
Q2 20262 holders, $19m33 holders, $39.1bn
MYGN

Myriad Genetics Inc

Holders
3
Reported value
$286m
Buyers
2
Sellers
1

Breadth +1 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUP
JNJ

Johnson & Johnson

Holders
31
Reported value
$19.0bn
Buyers
16
Sellers
16

Breadth 0 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2023

Among the 33 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only MYGN (2)

Artisan Partners LP, Glenview Capital Management LLC

Only JNJ (30)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, MFS Investment Management, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Squarepoint Ops LLC, Susquehanna International Group LLP, T. Rowe Price Associates Inc, Tudor Investment Corp, and 5 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →